2,2-bis(4-glycidyloxyphenyl)propane has been researched along with gw9662 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
Deng, G; Jiang, H; Liu, H; Liu, Z; Luo, X; Shen, X; Ye, F; Zhu, W | 1 |
Balaguer, P; Carlavan, I; Lemaire, G; Nicolas, JC; Perrin, A; Pillon, A; Seimandi, M; Vignon, F; Voegel, JJ | 1 |
Barton, S; Harris, G; Morales, VM; Nakajima, A; Osawa, E; Saubermann, LJ; Schaefer, KL; Takahashi, H | 1 |
Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C | 1 |
Abo-Warda, SM; El-Bassossy, HM; Fahmy, A | 1 |
7 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and gw9662
Article | Year |
---|---|
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling.
Topics: Computer Simulation; Dipeptides; Drug Design; Models, Chemical; Models, Molecular; Molecular Structure; PPAR gamma; Stereoisomerism; Structure-Activity Relationship; Tryptophan | 2008 |
Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
Topics: Anilides; Benzhydryl Compounds; Butyrates; DNA-Binding Proteins; Epoxy Compounds; Genes, Reporter; HeLa Cells; Humans; Inhibitory Concentration 50; Ligands; Luciferases; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; PPAR alpha; PPAR delta; PPAR gamma; Rosiglitazone; Saccharomyces cerevisiae Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 2005 |
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
Topics: Amino Acid Chloromethyl Ketones; Anilides; Animals; Apoptosis; Benzamides; Benzhydryl Compounds; Caco-2 Cells; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Shape; Colorectal Neoplasms; Dose-Response Relationship, Drug; Epoxy Compounds; HT29 Cells; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; PPAR delta; PPAR gamma; Proteasome Endopeptidase Complex; Pyridines; Tubulin; Xenograft Model Antitumor Assays | 2007 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Topics: Angiogenesis Inhibitors; Anilides; Benzhydryl Compounds; Benzophenones; Binding Sites; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endothelial Cells; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; Nitrobenzenes; PPAR gamma; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Transport; RNA Interference; RNA, Messenger; Rosiglitazone; Sulfonamides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transfection; Tyrosine; Vascular Endothelial Growth Factor A | 2010 |
Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.
Topics: Anilides; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Epoxy Compounds; Flavonoids; Glycation End Products, Advanced; Hyperinsulinism; In Vitro Techniques; Insulin; Insulin Resistance; Lipids; Luteolin; Male; Muscle, Smooth, Vascular; Nitric Oxide; PPAR gamma; Rats; Reactive Oxygen Species; Vasoconstriction | 2014 |